Advertisement

Can This Growth Stock Sustain Its Recent Momentum?

Can This Growth Stock Sustain Its Recent Momentum?

The novel coronavirus pandemic is turning out to be a tailwind for Xilinx (NASDAQ: XLNX), giving the chipmaker's business a nice shot in the arm, as evident in its latest quarterly results. Xilinx's first-quarter results for fiscal 2021 were better than estimates -- which was not surprising, as the company had recently increased its guidance. Xilinx's top line dropped 14% year over year to $727 million during the quarter.